Central Bank Trust Co Lowers stake in Metlife Inc (MET)

Metlife Inc (MET) : Central Bank Trust Co reduced its stake in Metlife Inc by 50.95% during the most recent quarter end. The investment management company now holds a total of 878 shares of Metlife Inc which is valued at $41,459 after selling 912 shares in Metlife Inc , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.Metlife Inc makes up approximately 0.01% of Central Bank Trust Co’s portfolio.

Other Hedge Funds, Including , Arvest Bank Trust Division added MET to its portfolio by purchasing 4,973 company shares during the most recent quarter which is valued at $234,825. Metlife Inc makes up approx 0.02% of Arvest Bank Trust Division’s portfolio.Hefty Wealth Partners boosted its stake in MET in the latest quarter, The investment management firm added 21,456 additional shares and now holds a total of 21,582 shares of Metlife Inc which is valued at $992,556. Metlife Inc makes up approx 0.76% of Hefty Wealth Partners’s portfolio.Franklin Street Advisors Inc Nc boosted its stake in MET in the latest quarter, The investment management firm added 7,733 additional shares and now holds a total of 124,962 shares of Metlife Inc which is valued at $5,747,002. Metlife Inc makes up approx 1.06% of Franklin Street Advisors Inc Nc’s portfolio.Washington Trust Bank boosted its stake in MET in the latest quarter, The investment management firm added 327 additional shares and now holds a total of 6,535 shares of Metlife Inc which is valued at $300,545. Metlife Inc makes up approx 0.07% of Washington Trust Bank’s portfolio. Lvm Capital Management Ltdmi sold out all of its stake in MET during the most recent quarter. The investment firm sold 14,800 shares of MET which is valued $680,652.

Metlife Inc opened for trading at $46.88 and hit $47.355 on the upside on Friday, eventually ending the session at $47.22, with a gain of 0.15% or 0.07 points. The heightened volatility saw the trading volume jump to 92,48,369 shares. Company has a market cap of $51,889 M.

On the company’s financial health, Metlife Inc reported $0.83 EPS for the quarter, missing the analyst consensus estimate by $ -0.52 based on the information available during the earnings call on Aug 3, 2016. Analyst had a consensus of $1.35. The company had revenue of $16955.00 million for the quarter, compared to analysts expectations of $17201.68 million. The company’s revenue was down -2.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.56 EPS.

Many Wall Street Analysts have commented on Metlife Inc. Metlife Inc was Initiated by Credit Suisse to “Neutral” on Oct 7, 2016. Metlife Inc was Resumed by Wells Fargo to “Outperform” on Sep 23, 2016. Company shares were Reiterated by FBR Capital on Aug 29, 2016 to “Outperform”, Firm has raised the Price Target to $ 54 from a previous price target of $51 .

MetLife Inc. (MetLife) is a provider of life insurance annuities employee benefits and asset management. The Company’s segments include Retail; Group Voluntary & Worksite Benefits and Corporate Benefit Funding. Its three geographic segments are Latin America (collectively the Americas); Asia and Europe the Middle East and Africa (EMEA). In addition MetLife’s Corporate & Other includes MetLife Home Loans LLC (MLHL) the surviving non-bank entity of the merger of MetLife Bank National Association (MetLife Bank) with and into MLHL and other business activities. Through its subsidiaries and affiliates it operates in the United States Japan Latin America Asia Europe and the Middle East. The Company‘s businesses in the Americas offer a range of protection products and services.

Leave a Reply

Metlife Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Metlife Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.